CERTAIN CONFIDENTIAL PORTIONS HAVE BEEN REDACTED FROM THIS EXHIBIT BECAUSE THEY ARE BOTH (i) NOT MATERIAL AND (ii) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. INFORMATION THAT HAS BEEN OMITTED HAS BEEN IDENTIFIED IN THIS DOCUMENT WITH A...
Nanobiotix S.A. • June 5th, 2020 • Pharmaceutical preparations
Company
Filed
June 5th, 2020
Industry

See All (5)

Exclusive License and Collaboration Agreement
License and Collaboration Agreement • June 5th, 2020 • Nanobiotix S.A. • Pharmaceutical preparations • New York
Contract Type
Filed
June 5th, 2020
Company
Industry
Jurisdiction
THIS EXCLUSIVE LICENSE AND COLLABORATION AGREEMENT IS ENTERED INTO EFFECTIVE AS OF AUGUST 06, 2012 (THE ‘‘EFFECTIVE DATE”) BETWEEN:

Amendment #1 to the Exclusive License and Collaboration Agreement
The Exclusive License and Collaboration Agreement • June 5th, 2020 • Nanobiotix S.A. • Pharmaceutical preparations
Contract Type
Filed
June 5th, 2020
Company
Industry

AMENDED AND RESTATED STRATEGIC COLLABORATION AGREEMENT
Strategic Collaboration Agreement • June 5th, 2020 • Nanobiotix S.A. • Pharmaceutical preparations • Texas
Contract Type
Filed
June 5th, 2020
Company
Industry
Jurisdiction

Contract number (FI No): 89427 Contract number (FI No): 89987 Serapis No: 2018-0245 European Investment Bank (the Bank) - and - Nanobiotix (the Company) Royalty Agreement Matter ref 1M0186.000509 PAARB/1864409 Hogan Lovells (Paris) LLP 17 avenue...
Royalty Agreement • June 5th, 2020 • Nanobiotix S.A. • Pharmaceutical preparations
Contract Type
Filed
June 5th, 2020
Company
Industry

0001140361-20-013192 Sample Contracts

Filter & Search